Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...